Rafael Zaragoza

Summary

Country: Spain

Publications

  1. ncbi Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
    Rafael Zaragoza
    Servicio de Medicina Intensiva, Hospital Universitario Dr Peset, Valencia, Spain
    Ther Clin Risk Manag 4:1261-80. 2008
  2. ncbi The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit
    R Zaragoza
    Intensive Care Unit, Hospital Universitario Dr Peset, Avda Gaspar Aguilar, 90 46017 Valencia, Spain
    Clin Microbiol Infect 9:412-8. 2003
  3. ncbi Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy
    Rafael Zaragoza
    Intensive Care Unit, Hospital Universitario Peset, Av Gaspar Aguilar 90, 46017 Valencia, Spain
    Rev Iberoam Micol 23:59-63. 2006
  4. ncbi Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients
    R Zaragoza
    Intensive Care Unit, Hospital Universitario Dr Peset, Valencia, Spain
    Clin Microbiol Infect 15:592-5. 2009
  5. ncbi Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
    Javier Peman
    Department of Microbiology, Hospital Universitario La Fe, Av Campanar, 21, Valencia, 46009, Spain
    BMC Infect Dis 11:60. 2011
  6. ncbi Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality
    Rafael Zaragoza
    Intensive Care Unit and Department of Microbiology, Valencia, Spain
    Clin Vaccine Immunol 16:1527-8. 2009
  7. ncbi [Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?]
    Rafael Zaragoza
    Servicio de Medicina Intensiva, Hospital Universitario Dr Peset, Valencia, Espana
    Rev Iberoam Micol 25:203-7. 2008
  8. ncbi Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function
    F Alvarez-Lerma
    Servicio de Medicina Intensiva, Hospital Universitari de Mar, Autonomous University of Barcelona, Spain
    J Chemother 20:93-100. 2008
  9. ncbi Update on invasive mycoses by filamentous fungi in critically ill patients
    Javier Peman
    Servicio de Microbiologia, Hospital Universitario La Fe, Valencia, Spain
    Enferm Infecc Microbiol Clin 29:36-41. 2011
  10. ncbi Current diagnostic approaches to invasive candidiasis in critical care settings
    Javier Peman
    Servicio de Microbiologia, Hospital Universitario La Fe, Valencia, Spain
    Mycoses 53:424-33. 2010

Collaborators

Detail Information

Publications15

  1. ncbi Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
    Rafael Zaragoza
    Servicio de Medicina Intensiva, Hospital Universitario Dr Peset, Valencia, Spain
    Ther Clin Risk Manag 4:1261-80. 2008
    ..In addition, the possibility of antifungal combination therapy might be considered in solid organ transplant and hematological patients...
  2. ncbi The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit
    R Zaragoza
    Intensive Care Unit, Hospital Universitario Dr Peset, Avda Gaspar Aguilar, 90 46017 Valencia, Spain
    Clin Microbiol Infect 9:412-8. 2003
    ....
  3. ncbi Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy
    Rafael Zaragoza
    Intensive Care Unit, Hospital Universitario Peset, Av Gaspar Aguilar 90, 46017 Valencia, Spain
    Rev Iberoam Micol 23:59-63. 2006
    ..The possibility of using antifungal combination therapy in these types of patients should be considered...
  4. ncbi Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients
    R Zaragoza
    Intensive Care Unit, Hospital Universitario Dr Peset, Valencia, Spain
    Clin Microbiol Infect 15:592-5. 2009
    ..2% vs. 22.7%). Multivariate analysis confirmed that a positive CAGTA result was the only protective factor to be independently associated with ICU mortality (beta coefficient = -0.3856; 95% confidence interval = -0.648 to -0.123)...
  5. ncbi Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients
    Javier Peman
    Department of Microbiology, Hospital Universitario La Fe, Av Campanar, 21, Valencia, 46009, Spain
    BMC Infect Dis 11:60. 2011
    ..This test provides a rapid and simple diagnosis of IC (84.4% sensitivity and 94.7% specificity). The aim of this study is to identify the patients who could be benefited by the use of CAGTA test in critical care setting...
  6. ncbi Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality
    Rafael Zaragoza
    Intensive Care Unit and Department of Microbiology, Valencia, Spain
    Clin Vaccine Immunol 16:1527-8. 2009
    ..Thus, antifungal treatment should be considered when CAGTA titers are increasing in critically ill patients...
  7. ncbi [Is the use of antifungal management advisable in critical patients with positive isolation of Candida spp. from intraabdominal clinical samples?]
    Rafael Zaragoza
    Servicio de Medicina Intensiva, Hospital Universitario Dr Peset, Valencia, Espana
    Rev Iberoam Micol 25:203-7. 2008
    ..An algorithm based on this approach has been provided to assess early treatment in surgical patients with yeasts isolated from intra-abdominal samples...
  8. ncbi Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function
    F Alvarez-Lerma
    Servicio de Medicina Intensiva, Hospital Universitari de Mar, Autonomous University of Barcelona, Spain
    J Chemother 20:93-100. 2008
    ..v. voriconazole (60% size=1>vs. 75%, P = 0.385). The use of i.v. voriconazole in ICU patients with pretreatment impaired renal function was not associated with renal or liver damage nor with an increase in ICU mortality...
  9. ncbi Update on invasive mycoses by filamentous fungi in critically ill patients
    Javier Peman
    Servicio de Microbiologia, Hospital Universitario La Fe, Valencia, Spain
    Enferm Infecc Microbiol Clin 29:36-41. 2011
    ....
  10. ncbi Current diagnostic approaches to invasive candidiasis in critical care settings
    Javier Peman
    Servicio de Microbiologia, Hospital Universitario La Fe, Valencia, Spain
    Mycoses 53:424-33. 2010
    ..Currently, the combination of prediction rules and non-culture microbiological tools could be the clue for improving the diagnosis and prognosis of invasive fungal infections in critically ill patients...
  11. ncbi Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock
    Arturo Artero
    Department of Internal Medicine, Hospital Universitario Dr Peset Av Gaspar Aguilar 90, 46017 Valencia, Spain
    J Crit Care 25:276-81. 2010
    ..The purpose of the study was to determine the independent risk factors on mortality in patients with community-acquired severe sepsis and septic shock...
  12. ncbi Severe 2009 A/H1N1v influenza in pregnant women in Spain
    Enrique Maravi-Poma
    Intensive Care Unit, Hospital Virgen del Camino, Pamplona, Spain
    Crit Care Med 39:945-51. 2011
    ..To describe the severity of the 2009 influenza A/H1N1v illness among pregnant women admitted to Spanish intensive care units...
  13. ncbi Combined use of nonculture-based lab techniques in the diagnosis and management of critically ill patients with invasive fungal infections
    Javier Peman
    Servicio de Microbiologia, Hospital Universitario y Politécnico La Fe, Valencia, Spain
    Expert Rev Anti Infect Ther 10:1321-30. 2012
    ....
  14. ncbi Critical overview of clinical guidelines relating to invasive fungal infections
    Márcio Borges Sá
    Servicio de Medicina Intensiva, Hospital Son Llatzer, Carretera de Manacor, Palma de Mallorca, Spain
    Int J Antimicrob Agents 32:S155-9. 2008
    ..In this paper, we have put together a critical overview of the role of guidelines for IFIs, with emphasis on non-neutropenic critical patients...
  15. ncbi [Antifungal treatment options in the critically ill patient]
    Rafael Zaragoza
    Servicio de Medicina Intensiva, Hospital Universitario Dr Peset, Valencia, Espana
    Rev Iberoam Micol 29:108-13. 2012
    ..Voriconazole should be recommended for invasive aspergillosis as a first line option...